Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels

Coronary Artery Disease

Volumn 18, Issue 7, 2007, Pages 559-564

  Hoffmann, Rainer ^a   Hamm, Christian ^b   Nienaber, Christoph A ^c   Levenson, Benny ^d   Bonzel, Tassilo ^e   Sabin, Georg ^f   Senges, Jochen ^g   Zahn, Ralf ^h   Tebbe, Ulrich ⁱ   Pfannebecker, Thomas ^j   Richardt, Hans Gert ^k   Schneider, Steffen ^g   Kelm, Malte ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d Division of Cardiology   (Germany)

^e KLINIKUM FULDA   (Germany)

^f ELISABETH KRANKENHAUS ESSEN   (Germany)

^g Heart Center Ludwigshafen   (Germany)

^h KLINIKUM NÜRNBERG   (Germany)

ⁱ KLINIKUM LIPPE DETMOLD   (Germany)

^j Medical Affairs Cordis Germany   (Germany)

^k Herzzentrum Segeberger Kliniken   (Germany)

more..

Author keywords

Drugs; Saphenous vein grafts; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RAPAMYCIN; RECEPTOR BLOCKING AGENT; TICLOPIDINE;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IMPLANT REGISTRY; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; REGISTRIES; SAPHENOUS VEIN; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 35048865818     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282ef5b40     Document Type: Article

References (20)

1. Fitzgibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: long term angiographic study. J Am Coll Cardiol 1991;17:1075-1080.
2. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patients outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626.
3. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-747.
4. Wong SC, Baim DS, Schatz RA, Teirstein PS, King SB 3rd, Curry RC Jr, et al. Immediate results and late out-comes after stent implantation in saphenous vein graft lesions: the multi-center U.S. Palmaz-Schatz stent experience. J Am Coll Cardiol 1995;26:704-712.
5. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al., RAVEL Study Group. A randomized comparison of sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1173-1180.
6. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
7. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al., TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221- 231.
8. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348:1537-1545.
9. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, et al. Patterns an mechanisms of in-stent restenosis. Circulation 1996;94:1247-1254.
10. Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, Makkar RR. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Cath and Cardiovascular Interven 2005;66:507-511.
11. Tsuchida K, Ong ATL, Aoki J, van Mieghem CAG, Rodriguez-Granillo GA, Valgimigli M, et al. Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents. Am J Cardiol 2005;96:395-398.
12. Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pinnow E, et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006;97:34-37.
13. Zahn R, Hamm CW, Schneider S, Zeymer U, Nienaber CA, Richardt G, et al.; German Cypher Stent Registry. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). Am J Cardiol 2005;95:1302-1308.
14. Zahn R, Hamm CW, Zeymer U, Schneider S, Nienaber CA, Richardt G, et al., for the German Cypher Registry. 'Real life' use of sirolimus-eluting stents in Germany. Results from the prospective multi-centre German Cypher Registry. Z Kardiol 2004;93:287-294.
15. Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt R, Kelm M, et al., for the German Cypher Stent Registry. Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multi-center German Cypher Stent Registry. Am Heart J 2006;152:1146-1152.
16. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky A, Kent KM, et al. Are we making progress with percutaneous saphenous vein graft treatment? J Am Coll Cardiol 2001;38:150-154.
17. Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pinnow E, et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006;97:34-37.
18. Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J, et al. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol 2005;45:989-994.
19. Hoffmann R, Pohl T, Köster R, Blindt R, Boeckstegers P, Heitzer T. Implantation of paclitaxel-eluting stents in saphenous vein grafts. Clinical and angiographic follow-up results from a multicenter study. Heart 2007;93:331-334.
20. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts. J Am Coll Cardiol 2006;48:2423-2431.